Opportunity
DIBBS #SPE2DP-26-T-2821
DLA Solicitation for Guaifenesin Extended-Release Tablets, 600mg, 500 Count Bottles
Posted
April 10, 2026
Respond By
April 15, 2026
Identifier
SPE2DP-26-T-2821
NAICS
424210
The Defense Logistics Agency Troop Support Medical Supply Chain is soliciting quotations for Guaifenesin Extended-Release Tablets, 600mg, 500 count bottles, for delivery to military units at Fort Bliss, TX, and Fort Bragg, NC. - Government Buyer: - Defense Logistics Agency (DLA) - Sub-agency: DLA Troop Support Medical Supply Chain Pharm FSA - Office: DLA Troop Support Medical Supply Chain Pharm FSA - OEMs (Original Equipment Manufacturers): - Reckitt Benckiser LLC (part number NDC63824-0008-50) - The Harvard Drug Group, L.L.C. (part number NDC00904-6986-04) - Products Requested: - Guaifenesin Extended-Release Tablets, 600mg, 500 count bottles - National Stock Number (NSN): 6505-01-340-5446 - Quantity: 2 bottles (1 per delivery location) - Approved sources: Reckitt Benckiser LLC and The Harvard Drug Group, L.L.C. - Packaging and marking must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1 - Shelf life requirement: 36 months total, with at least 31 months remaining at delivery - Notable Requirements: - Delivery required within 20 calendar days from order date - Compliance with DFARS clauses for cybersecurity and hazardous material handling - Fast award process - Delivery Locations: - Fort Bliss, TX (21287 Light Infantry Avenue, Fort Bliss, TX 79918-2527) - Fort Bragg, NC (5234 Eagle Talon Dr Bldg X3063, Fort Bragg, NC 28310)
Description
GUAIFENESIN EXTENDE (QTY: 1, NSN: 6505-01-340-5446, Purchase Request: 7016282473) Approved Sources: - CAGE: 0MWS8, Part No: NDC63824-0008-50, Company: RECKITT BENCKISER LLC - CAGE: 1LEZ0, Part No: NDC00904-6986-04, Company: THE HARVARD DRUG GROUP, L.L.C.
GUAIFENESIN EXTENDE (QTY: 1, NSN: 6505-01-340-5446, Purchase Request: 7016261774) Approved Sources: - CAGE: 0MWS8, Part No: NDC63824-0008-50, Company: RECKITT BENCKISER LLC - CAGE: 1LEZ0, Part No: NDC00904-6986-04, Company: THE HARVARD DRUG GROUP, L.L.C.